Le Lézard
Classified in: Health, Covid-19 virus
Subjects: LEG, HSP, AVO, DEI

National Alliance for Hispanic Health Calls on Senate to Pass Critical Mental Health Legislation


WASHINGTON, Sept. 29, 2022 /PRNewswire/ -- "More than ever people are suffering. The need for mental health resources and services has been intensified and compounded by the stress, social isolation, and hardships brought on by the COVID-19 pandemic," said Jane L. Delgado, PhD, MS, President and CEO of the National Alliance for Hispanic Health, the Nation's leading Hispanic health advocacy group, in announcing support for the bipartisan Restoring Hope for Mental Health and Well-Being Act of 2022. "The Senate must act now to address the mental health needs of communities across the country."

In a letter to the Senate Committee on Health, Education, Labor, and Pensions, the Alliance urged Senators to swiftly pass the Restoring Hope for Mental Health and Well-Being Act of 2022 to authorize critical investments in mental health and substance use treatment and prevention services. The Act, which passed the House of Representatives in June, will fund community mental health services, substance use disorder prevention, treatment, and recovery support, and youth suicide prevention programs, many of which are set to expire at the end of the fiscal year. In addition, the legislation will support maternal mental health care, strengthen and diversify the mental health care workforce, and advance mental health parity in health plans. 

Suicide is the second leading cause of death among youth and young adults. Yet the majority of individuals living with a mental illness do not receive treatment. Two-thirds of Hispanic adults living with a mental illness and more than nine in ten Hispanics living with a substance use disorder do not receive treatment, highlighting the unique barriers faced by Hispanics and other underserved communities and underscoring the urgent need to reauthorize mental health and substance use treatment and prevention programs.

"As National Suicide Prevention Month draws to a close, we urge Senators to keep mental health at the forefront of their legislative priorities and enact these crucial mental health provisions before the end of the legislative session," concluded Dr. Delgado.

About the National Alliance for Hispanic Health (The Alliance)
The Alliance is the nation's foremost science-based source of information and trusted advocate for the health of Hispanics in the United States with a mission to achieve the best health for all. For more information visit us at www.healthyamericas.org

SOURCE National Alliance for Hispanic Health


These press releases may also interest you

at 03:01
'Textbook of Tinnitus' is a comprehensive textbook that describes tinnitus, how it is caused, and state-of-the art interventions such as Lenire.Top-ranked tinnitus expert authors of the Textbook of Tinnitus state that Lenire's clinical trial results...

at 03:00
In a significant stride towards preventing antimicrobial resistance, Smart Blood Analytics Swiss proudly announces the attainment of EU-MDR (European Medical Device Regulation)1 certification for their VIRUS vs. BACTERIA Clinical Decision Support...

at 02:43
January-March 2024 Net sales, which for the quarter only included royalties, amounted to SEK 156 (520)Net earnings amounted to KSEK -2,946 (-51,658), where exchange rate effects of KSEK 21 358 (435) had a substantial impact.Earnings per share before...

at 02:27
Market Overview The Global Biometric Technologies Market is expected to grow at a compound annual growth rate (CAGR) of around 12% between 2024 and 2031, from an estimated USD 38 billion in 2023 to approximately USD 120 billion by 2031. Our study...

at 02:05
Locate Bio, a pioneering orthobiologics company, today announces the successful completion of an oversubscribed £9.2 million funding round from both new investors and existing investors, Mercia Ventures and BGF. The proceeds will fund a clinical...

at 02:05
Positive topline results from the DESTINY-Breast06 phase 3 trial showed that ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to standard of...



News published on and distributed by: